Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
So What: There weren't any company announcements today, so it appears this was not a news-driven event. In early trading there was incredibly high volume that settled down later in the day.
Now What: Options volume was unusually high yesterday in both puts and calls, so the stock's move back up today could have been profit-taking on options positions. VIVUS is waiting for a decision on Qnexa from the Food and Drug Administration, so investors are betting on a move, one way or the other. The advisory panel voted against Qnexa, so it may be a little early to jump on this stock until we hear more positive news.
Interested in more info on VIVUS? Add it to your watchlist by clicking here.
Fool contributor Travis Hoium does not have a position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings, or follow his Motley Fool CAPS picks at TMFFlushDraw.
Try any of our Foolish newsletter services free for 30 days. True to its name, The Motley Fool is made up of a motley assortment of writers and analysts, each with a unique perspective; sometimes we agree, sometimes we disagree, but we all believe in the power of learning from each other through our Foolish community. The Fool has a disclosure policy.